Pain in Biologic‐Treated Rheumatoid Arthritis Patients: The Role of Illness Perception Before and After the COVID‐19 Pandemic
Musculoskeletal Care · 2024
DOI: 10.1002/msc.1958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Musculoskeletal Care, 2024. Verfasst von Alexandra Husivargova Theofanidis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social and Behavioural Medicine, Faculty of Medicine, PJ Safarik University, Kosice, Slovakia. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Agentúra na Podporu Vྭskumu a Vྭvoja/Slovak Research and Development Agency, Agentúra na Podporu Výskumu a Vývoja.
Abstract (Originalsprache)
Background
We aimed to assess the role of the COVID‐19 pandemic in the association of clinical, physical, and psychological factors with pain in Rheumatoid Arthritis (RA) patients.
Methods
We included 103 RA patients (81.6% females; mean age 56.1 ± 13.8 years). Patients filled out the VAS‐pain, GAD‐7, PHQ‐9, MFI‐20, and B‐IPQ. Paired sample t ‐tests, correlations, and multiple regression analyses were used to analyse the data.
Results
Our results showed significantly worsened pain in the data collected post‐pandemic ( p ≤ 0.05). Pre‐pandemic, the final regression models showed an association between functional disability ( β = 0.24; p ≤ 0.05), illness perception ( β = 0.34; p ≤ 0.05) and pain. In post‐pandemic models, significant associations were found between fatigue ( β = 0.33; p ≤ 0.01) and illness perception ( β = 0.36; p ≤ 0.01) with pain. Positive illness perception was able to alleviate the associations between fatigue and depression with pain before and after the pandemic.
Conclusion
Findings indicate that patients with RA may have been negatively affected by the COVID‐19 pandemic given their vulnerability. Even though pharmacological treatment was not interrupted, post‐pandemic results showed significantly higher levels of experienced pain. Therefore, in addition to biological therapy, non‐pharmacological interventions, including psychological support aimed at diminishing negative illness perception, may be beneficial in reducing RA‐related pain, especially when dealing with a crisis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Social and Behavioural Medicine, Faculty of Medicine, PJ Safarik University, Kosice, Slovakia.
- Department of Health Psychology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- 1st Department of Internal Medicine, Faculty of Medicine, PJ Safarik University and L. Pasteur University Hospital, Kosice, Slovakia.
- Department of Health Psychology and Technology, University of Twente, Enschede, The Netherlands.
ORCID-Profile: Alexandra Husivargova Theofanidis, Vladimira Timkova, Zelmira Macejova, Dagmar Breznoscakova, Robbert Sanderman, Iveta Nagyova
Förderung
- Agentúra na Podporu Vྭskumu a Vྭvoja/Slovak Research and Development Agency
- Agentúra na Podporu Výskumu a Vývoja
Zitieren
APA
Theofanidis, A. H., Timkova, V., Macejova, Z., Kotradyova, Z., Breznoscakova, D., Sanderman, R., & Nagyova, I. (2024). Pain in Biologic‐Treated Rheumatoid Arthritis Patients: The Role of Illness Perception Before and After the COVID‐19 Pandemic. Musculoskeletal Care. https://doi.org/10.1002/msc.1958
Vancouver
Theofanidis AH, Timkova V, Macejova Z, Kotradyova Z, Breznoscakova D, Sanderman R, et al. Pain in Biologic‐Treated Rheumatoid Arthritis Patients: The Role of Illness Perception Before and After the COVID‐19 Pandemic. Musculoskeletal Care. 2024. doi:10.1002/msc.1958
BibTeX
@article{Theofanidis2024,
author = {Theofanidis, Alexandra Husivargova and Timkova, Vladimira and Macejova, Zelmira and Kotradyova, Zuzana and Breznoscakova, Dagmar and Sanderman, Robbert and Nagyova, Iveta},
title = {Pain in Biologic‐Treated Rheumatoid Arthritis Patients: The Role of Illness Perception Before and After the COVID‐19 Pandemic},
journal = {Musculoskeletal Care},
year = {2024},
doi = {10.1002/msc.1958}
}
EUVIMED